Corrigendum to "Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers": Translational Oncology 2022 Nov; 25:101511

Affiliations

¹ St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India.
² St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
³ St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India.
⁴ Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
⁵ MOSC Medical College, Kolenchery, Kerala, India.
⁶ Sri Shankara Cancer Hospital and Research Centre, Bangalore, India.
⁷ Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
⁸ Clinical Trials and Statistical Unit, The Institute of Cancer Research, London, UK.
⁹ Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Centre for Global Oncology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK. Electronic address: Anguraj.sadanandam@icr.ac.uk.

Published Erratum

Aruna Korlimarla et al. Transl Oncol. 2023 Jan.

. 2023 Jan:27:101574.

doi: 10.1016/j.tranon.2022.101574. Epub 2022 Nov 3.

¹ St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India.
² St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
³ St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India.
⁴ Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
⁵ MOSC Medical College, Kolenchery, Kerala, India.
⁶ Sri Shankara Cancer Hospital and Research Centre, Bangalore, India.
⁷ Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
⁸ Clinical Trials and Statistical Unit, The Institute of Cancer Research, London, UK.
⁹ Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Centre for Global Oncology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK. Electronic address: Anguraj.sadanandam@icr.ac.uk.

No abstract available

Erratum for

Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.
Korlimarla A, Ps H, Prabhu J, Ragulan C, Patil Y, Vp S, Desai K, Mathews A, Appachu S, Diwakar RB, Bs S, Melcher A, Cheang M, Sadanandam A. Korlimarla A, et al. Transl Oncol. 2022 Nov;25:101511. doi: 10.1016/j.tranon.2022.101511. Epub 2022 Aug 11. Transl Oncol. 2022. PMID: 35964339 Free PMC article.